Related Experiment Video
Updated: Feb 3, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Extended Combined Neonatal Treatment With Erythropoietin Plus Melatonin Prevents Posthemorrhagic Hydrocephalus of
Shenandoah Robinson1, Fatu S Conteh1, Akosua Y Oppong1
1Division of Pediatric Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Insights
Posthemorrhagic hydrocephalus of prematurity (PHHP) is a challenge. A new rat model shows neonatal erythropoietin (EPO) plus melatonin (MLT) treatment can prevent PHHP's key features, offering a potential non-surgical therapy.
Area of Science:
- Neonatal Neurology
- Developmental Neuroscience
- Pediatric Critical Care
Background:
- Posthemorrhagic hydrocephalus of prematurity (PHHP) affects vulnerable preterm infants, often following intraventricular hemorrhage (IVH) and chorioamnionitis (CAM).
- Current treatments for PHHP are primarily surgical, necessitating the development of non-surgical therapeutic strategies.
- Preclinical models are crucial for understanding PHHP pathogenesis and testing novel interventions.
Purpose of the Study:
- To establish a preclinical model of PHHP using combined prenatal CAM and postnatal IVH in rats.
- To investigate the efficacy of neonatal systemic erythropoietin (EPO) plus melatonin (MLT) treatment in modulating PHHP development.
- To assess the impact of EPO+MLT on macrocephaly, ventriculomegaly, neurodevelopment, and brain microstructure.
Main Methods:
- Prenatal CAM induction followed by postnatal day 1 IVH in rat pups.
- Systemic administration of EPO+MLT or vehicle from postnatal day 2 to 10.
- Assessment of macrocephaly, ventriculomegaly (histology and MRI), cliff aversion behavior, ependymal cilia, YAP mRNA, GFAP expression, and diffusion tensor imaging (DTI).
Main Results:
- The CAM-IVH model recapitulated progressive macrocephaly, ventriculomegaly, and impaired cliff aversion behavior.
- Neonatal EPO+MLT treatment significantly prevented macrocephaly, reduced ventriculomegaly, and normalized cliff aversion performance.
- EPO+MLT treatment preserved ependymal motile cilia, normalized YAP mRNA levels, reduced GFAP, and improved white matter microstructural integrity on DTI.
Conclusions:
- Combined prenatal inflammation and early postnatal IVH in rats effectively models PHHP.
- Neonatal systemic EPO+MLT administration represents a promising non-surgical therapeutic strategy for PHHP.
- This preclinical study supports further investigation of EPO+MLT for preventing or treating PHHP in preterm infants.
Abstract:
Posthemorrhagic hydrocephalus of prematurity (PHHP) remains a global challenge. Early preterm infants (<32 weeks gestation), particularly those exposed to chorioamnionitis (CAM), are prone to intraventricular hemorrhage (IVH) and PHHP. We established an age-appropriate, preclinical model of PHHP with progressive macrocephaly and ventriculomegaly to test whether non-surgical neonatal treatment could modulate PHHP. We combined prenatal CAM and postnatal day 1 (P1, equivalent to 30 weeks human gestation) IVH in rats, and administered systemic erythropoietin (EPO) plus melatonin (MLT), or vehicle, from P2 to P10. CAM-IVH rats developed progressive macrocephaly through P21. Macrocephaly was accompanied by ventriculomegaly at P5 (histology), and P21 (ex vivo MRI). CAM-IVH rats showed impaired performance of cliff aversion, a neonatal neurodevelopmental test. Neonatal EPO+MLT treatment prevented macrocephaly and cliff aversion impairment, and significantly reduced ventriculomegaly. EPO+MLT treatment prevented matted or missing ependymal motile cilia observed in vehicle-treated CAM-IVH rats. EPO+MLT treatment also normalized ependymal yes-associated protein (YAP) mRNA levels, and reduced ependymal GFAP-immunolabeling. Vehicle-treated CAM-IVH rats exhibited loss of microstructural integrity on diffusion tensor imaging, which was normalized in EPO+MLT-treated CAM-IVH rats. In summary, combined prenatal systemic inflammation plus early postnatal IVH caused progressive macrocephaly, ventriculomegaly and delayed development of cliff aversion reminiscent of PHHP. Neonatal systemic EPO+MLT treatment prevented multiple hallmarks of PHHP, consistent with a clinically viable, non-surgical treatment strategy.
More Related Videos
14:59Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Related Concept Videos
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Gravitational Potential Energy for Extended Objects
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...